| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 133, 1085-1091, Copyright © 1993 by Endocrine Society
ARTICLES |
JS Smith, S Kawa, MW Cloyd and EB Thompson
University of Texas Medical Branch, Department of Human Biological Chemistry and Genetics, Galveston 77555-0645.
We examined the effect of chronic human immunodeficiency virus 1 (HIV- 1) infection on the growth of human leukemic CEM T cells exposed to compounds which act through several major hormone or hormone-like signal transduction systems. Three were not altered by HIV-1 infection. Micromolar 8-bromo-cAMP inhibited cell growth equally in uninfected and infected cells. At the concentrations tested, neither (Bu)2cAMP nor the stimulator of protein kinase C, phorbol 12-myristate 13-acetate, altered the growth of infected or uninfected cells. The synthetic prostaglandin analog enisoprost also inhibited both equally. However, responses to two basic signal transduction systems, calcium uptake and the glucocorticoid pathway, were influenced by HIV infection. In chronically HIV-infected cells increased sensitivity to lysis by the calcium ionophore A23187 was observed. Additionally, the infected cells contained reduced amounts of glucocorticoid receptor sites and showed a statistically significant shift toward resistance to glucocorticoid- induced apoptosis.
This article has been cited by other articles:
![]() |
N. Ismaili, R. Blind, and M. J. Garabedian Stabilization of the Unliganded Glucocorticoid Receptor by TSG101 J. Biol. Chem., March 25, 2005; 280(12): 11120 - 11126. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ogawa, M. B. Streiff, A. Bugayenko, and G. J. Kato Inhibition of PDE4 phosphodiesterase activity induces growth suppression, apoptosis, glucocorticoid sensitivity, p53, and p21WAF1/CIP1 proteins in human acute lymphoblastic leukemia cells Blood, May 1, 2002; 99(9): 3390 - 3397. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. NORBIATO, M. BEVILACQUA, T. VAGO, and M. CLERICI Glucocorticoid Resistance and the Immune Function in the Immunodeficiency Syndrome Ann. N.Y. Acad. Sci., May 1, 1998; 840(1): 835 - 847. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |